ClinicalTrials.gg
Not yet recruitingNCT06350643Updated Oct 27, 2026

Quit and Screen Project

An interventional study of Quit and Screen Project training and G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training in Knowledge, Attitudes and Behavioral Intention, sponsored by University of Arkansas. Not yet recruiting at 1 site in United States. Open to participants aged 21 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by University of Arkansas · Not applicable, Interventional, and Other

How we know

Updated Oct 27, 2026Start date movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
21 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 585 studies in Behavior with a site in United States — 87 open to participants now, 118 under way, 2 of them phase 3. Behavior · United States.

Planned enrollment
145th of 495
300 · median 121
Started
2027
with 2 others
No phase
431 of 585
74 open now
Primary completion
2027-04
later than 53 of 116 live
Registered
495th of 585
by date

Among the 585 studies in Behavior with a site in United States, this one is the 145th largest by planned enrollment of the 495 interventional ones that give a count, is one of 3 that started in 2027, is one of 431 with no phase, reaches primary completion later than 53 of the 116 other live ones, and was the 495th registered.

Behavior

1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.

Browse Behavior studies →

Open to participants now

87 of the 585 studies in Behavior with a site in United States are open now. Recruiting first, the newest first:

82 more — sign in →

All 87 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.

This study: 21 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 585 studies in Behavior with a site in United States, or all of them as a file.
02

Study summary

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Read the detailed description

This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.

In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.

03

Conditions studied

  • Knowledge
  • Attitudes
  • Behavioral Intention

Browse trials for

04

Who can participate

Ages eligible
21 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current National Medical Association (NMA) member
  • Serves a patient clientele who smokes
  • At least 20% of time (1 day per week) devoted to clinical care
  • Currently screens clients for tobacco use in the clinic
  • Have the capacity to refer smokers to a patient navigator
  • Willing to provide
  • Will provide contact email, address and phone.

Exclusion criteria

Exclusion Criteria:

  • None
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Quit and Screen Project training alone

    Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training .

    Other: Quit and Screen Project training

  • Experimental
    Quit and Screen Project training + G02 Lung Cancer Screening training

    In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training.

    Other: Quit and Screen Project training · Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Interventions

  • OtherQuit and Screen Project training

    This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

  • OtherG02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

    The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.

06

What researchers measure

Primary outcomes

  1. Familiarity with treatment guidelines for tobacco and nicotine treatment

    Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  2. Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation

    These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  3. Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients

    Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  4. Provider Perceptions about patient barriers to smoking cessation

    Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  5. Behavioral intentions to screen and advise patients about smoking cessation

    A set of questions based on the Theory of Planned Behavior assessed provider's intention to screen patients for tobacco use and provide them interventions and referrals for treatment.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  6. Familiarity with lung cancer screening guidelines

    Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  7. Knowledge about low dose computed tomography for lung cancer screening

    Familiarity with treatment guidelines was assessed using an modified question from the questions published by Kota et al. 2022, Carter-Bawa et al. 2022, and the National Cancer Institute National Survey of Primary Care Physicians' Recommendations \& Practices for Breast, Cervical, Lung, \& Colorectal Cancer Screening.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  8. Perceptions about shared decision-making for low dose computed tomography for lung cancer screening

    Questions were modified from the questions published by Forcino et al. in 2018.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  9. Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening

    Questions were modified from questions published by Coughlin et al. 2020.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  10. Provider Perceptions about patient barriers to get screened for lung cancer

    Perceptions about patient barriers to getting screened for lung cancer were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  11. Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography

    A set of questions based on the Theory of Planned Behavior assessed provider's intention to advise patients who smoke to get screened for lung cancer via low dose computed tomography.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

Secondary outcomes

  1. Characteristics of enrolled healthcare providers

    Study process tracking metrics will be used to assess the demographic, training, and clinical practice characteristics of providers who enroll in the training.

    Time frame: This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.

  2. Retention: Percent of providers complete the training after enrolling

    Study process tracking metrics will be used to assess retention of providers who enroll in the training.

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  3. Adherence to completing training modules: Percent of modules completed

    Study process tracking metrics and training completion data will be used to assess the percent of training modules completed (i.e., the number of modules completed divided by the total available modules).

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

  4. Preferences regarding training

    Questions will assess provider feedback on the online training module.

    Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.

  5. Satisfaction with training

    Questions will assess provider satisfaction on the online training module.

    Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.

07

Study locations

1 site
  • Virginia Commonwealth Univesity
    Richmond, Virginia 23284, United States
    • Mignonne Guy, PhD · Contactmguy@vcu.edu · 804-828-1731
    • Mignonne Guy, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Apr 2027, 3 months later.

Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 3 months is below that.

Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: start Sep 2026 → Jan 2027 and completion Apr 2027 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2024
First posted
Apr 5, 2024
StartEst.
Jan 1, 2027was Sep 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
Jul 1, 2027was Apr 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Jan 1, 2027
Oct 27, 2026
Study completion
Apr 2027→Jul 1, 2027
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Start date Sep 1, 2026→Jan 1, 2027
    Study completion Apr 2027→Jul 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06350643
Collaborators
Virginia Commonwealth University, Coalition for a Tobacco Free Arkansas, National Institute on Minority Health and Health Disparities (NIMHD), National Medical Association
Responsible party
Sponsor
First posted
Apr 5, 2024
Start date
Jan 1, 2027 (estimated)
Primary completion
Apr 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Mignonne Guy, PhD
Contact
mguy@vcu.edu
804-828-1731
Ashley Clawson, PhD
Contact
aclawson2@uams.edu
501-526-6413
Pebbles Fagan, PhD, MPH
principal investigator · University of Arkansas
Mignonne Guy, PhD
principal investigator · Virginia Commonwealth University
Ashley Clawson, PhD
principal investigator · University of Arkansas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion